Overview

Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism

Status:
COMPLETED
Trial end date:
2024-03-12
Target enrollment:
Participant gender:
Summary
To study the efficacy and safety of finerenone in patients with primary aldosteronism
Phase:
PHASE4
Details
Lead Sponsor:
Chongqing Medical University
Treatments:
finerenone